1338
We describe the development of cutaneous scleroderma in 3 patients coincident with the use of bleomycin in low cumulative doses of less than 100 U.
 3 patients: Subject; 3: Subject.Population; cutaneous scleroderma: Effect; the use of bleomycin in low cumulative doses of less than 100 U.: Treatment; bleomycin: Treatment.Drug; less than 100 U.: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 3 patients: Subject; 3: Subject.Population; cutaneous scleroderma: Effect; the use of bleomycin in low cumulative doses of less than 100 U.: Treatment; bleomycin: Treatment.Drug; less than 100 U.: Treatment.Dosage